In an interview with the American Journal of Managed Care, Jesse Dresser discussed new federal legislation aimed at increasing transparency in the pharmacy benefit manager (PBM) industry. The reforms target practices such as rebate retention and price-linked fees that can obscure true drug costs and incentivize higher list prices. The law also prohibits PBM compensation tied to drug prices in Medicare Part D and grants CMS new authority to oversee PBM contracting practices and disputes involving pharmacies and health plans.
Listen to the full interview with the American Journal of Managed Care.
